Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition

Nephrol Dial Transplant. 2008 Apr;23(4):1274-7. doi: 10.1093/ndt/gfm745. Epub 2007 Nov 6.

Abstract

The activity of the renin-angiotensin-aldosterone system (RAAS) plays an important role in the development and progression of diabetic nephropathy. However, the effect of angiotensin-converting enzyme (ACE) inhibition on the RAAS appears to be modulated by a number of factors including the I/D polymorphism of the ACE genotype. In this study, we attempted to find independent correlates of ACE activity in 121 macroalbuminuric type 2 diabetic Iranian patients under chronic ACE inhibition. Both univariate and multivariate analyses were used. The presence of the D allele was independently associated with significantly higher levels of ACE activity (with the II genotype as reference, P < 0.001, B = 27.3, 95% CI = 17.6-37.1), and this association was not eliminated by potentially confounding variables. In conclusion, the D allele is a significant independent correlate of ACE activity in macroalbuminuric type 2 diabetic Iranian patients under long-term ACE inhibition.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Albuminuria / complications
  • Albuminuria / enzymology*
  • Albuminuria / epidemiology
  • Alleles
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Body Mass Index
  • DNA / genetics
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / enzymology
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetic Nephropathies / enzymology
  • Diabetic Nephropathies / etiology
  • Diabetic Nephropathies / prevention & control*
  • Female
  • Follow-Up Studies
  • Genotype
  • Humans
  • Iran / epidemiology
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A / blood*
  • Peptidyl-Dipeptidase A / drug effects
  • Peptidyl-Dipeptidase A / genetics
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Prevalence
  • Prognosis
  • Retrospective Studies
  • Severity of Illness Index
  • Time Factors

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • DNA
  • Peptidyl-Dipeptidase A